Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)

China flag China · Delayed Price · Currency is CNY
26.11
+0.21 (0.81%)
Apr 29, 2026, 3:00 PM CST
1.24%
Market Cap 11.25B
Revenue (ttm) 3.91B
Net Income (ttm) 590.51M
Shares Out 431.05M
EPS (ttm) 1.37
PE Ratio 19.05
Forward PE 14.47
Dividend 0.62 (2.39%)
Ex-Dividend Date Aug 8, 2025
Volume 3,550,862
Average Volume 3,567,923
Open 25.96
Previous Close 25.90
Day's Range 25.81 - 26.18
52-Week Range 24.61 - 31.46
Beta 0.43
RSI 59.69
Earnings Date Apr 25, 2026

About SHA:600993

Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells Chinese and Western medicines in China and internationally. The company offers functional cosmetics, functional care products and food, Chinese herbal medicines, and medical devices. It also manufactures, processes, and sells medicinal packaging materials, cosmetics, and Chinese medicines; and offers first and second category medical devices, household products, electronic products, daily necessities, hygiene products, and disinfection products, as... [Read more]

Sector Healthcare
Founded 1582
Employees 2,654
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600993
Full Company Profile

Financial Performance

In 2025, SHA:600993's revenue was 3.87 billion, an increase of 3.72% compared to the previous year's 3.73 billion. Earnings were 581.49 million, an increase of 10.11%.

Financial Statements

News

There is no news available yet.